Key facts
- Cirdan’s last known valuation is $44.6M (Oct 2024).
- It has raised $51.1M; the latest was Later Stage VC ($17.5M) in Mar 2026.
- Notable investors include Innovate UK, Salica Investments, Clarendon Fund Managers, Invest Northern Ireland, ABHI US Accelerator — 20 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 20 names
- ·Watchlist + deal alerts for Cirdan
- ·The full record, as it builds
Funding rounds
No funding rounds for Cirdan are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Cirdan
Developer of healthcare informatics software designed to offer imaging technology to accelerate and enhance diagnosis. The company's software offers the design and development of imaging sensors that are produced using X-ray, near-infrared, and visible light wavelengths in high-performance cameras, enabling healthcare professionals to make accurate diagnoses while improving efficiency across healthcare systems
- Sector
- Healthcare
- HQ
- Lisburn, United Kingdom
- Founded
- 2010
- Employees
- 121
- Website
- cirdan.com/
- Ownership
- Privately Held (backing)
Cirdan doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cirdan shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cirdan in its N-PORT filings yet. We sweep new filings monthly.